Browse by People

Collapse authors list.
Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J et al (show 24 more authors) , Darby, S, Meyer, T, Gillmore, R, Anthoney, A, Lind, P, Glimelius, B, Falk, S, Izbicki, JR, Middleton, GW, Cummins, S, Ross, PJ, Wasan, H, McDonald, A, Crosby, T, Ma, YT, Patel, K, Sherriff, D, Soomal, R, Borg, D, Sothi, S, Hammel, P, Hackert, T, Jackson, R and Büchler, MW (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). pp. 1011-1024.

Collapse authors list.
Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J et al (show 24 more authors) , Darby, S, Meyer, T, Gillmore, R, Anthoney, A, Lind, P, Glimelius, B, Falk, S, Izbicki, JR, Middleton, GW, Cummins, S, Ross, PJ, Wasan, H, McDonald, A, Crosby, T, Ma, YT, Patel, K, Sherriff, D, Soomal, R, Borg, D, Sothi, S, Hammel, P, Hackert, T, Jackson, R and Büchler, MW (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). 1011 - 1024.

Collapse authors list.
Ghaneh, P, Wong, WL, Titman, A, Plumpton, C, Vinjamuri, S, Johnson, C, Abu Hilal, M, Higginson, A, Smith, AM, Scarsbrook, A et al (show 10 more authors) , McKay, C, Sutcliffe, R, Kocher, H, Cunningham, D, Pereira, S, Davidson, B, Chang, D, Khan, S, Halloran, C ORCID: 0000-0002-5471-4178 and Neoptolemos, JP (2016) PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer. In: American Society of Clinical Oncology, 2016-6-3 - 2016-6-7, Chicago.